Anti-ACV1C/ ACVR1C/ ACVRLK7 monoclonal antibody

Anti-ACV1C/ ACVR1C/ ACVRLK7 antibody for FACS & in-vivo assay

Target products collectionGo to ACVR1C/ACVR1C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0029-Ab-1/ GM-Tg-hg-MP0029-Ab-2Anti-Human ACVR1C monoclonal antibodyHuman
GM-Tg-rg-MP0029-Ab-1/ GM-Tg-rg-MP0029-Ab-2Anti-Rat ACVR1C monoclonal antibodyRat
GM-Tg-mg-MP0029-Ab-1/ GM-Tg-mg-MP0029-Ab-2Anti-Mouse ACVR1C monoclonal antibodyMouse
GM-Tg-cynog-MP0029-Ab-1/ GM-Tg-cynog-MP0029-Ab-2Anti-Cynomolgus/ Rhesus macaque ACVR1C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0029-Ab-1/ GM-Tg-felg-MP0029-Ab-2Anti-Feline ACVR1C monoclonal antibodyFeline
GM-Tg-cang-MP0029-Ab-1/ GM-Tg-cang-MP0029-Ab-2Anti-Canine ACVR1C monoclonal antibodyCanine
GM-Tg-bovg-MP0029-Ab-1/ GM-Tg-bovg-MP0029-Ab-2Anti-Bovine ACVR1C monoclonal antibodyBovine
GM-Tg-equg-MP0029-Ab-1/ GM-Tg-equg-MP0029-Ab-2Anti-Equine ACVR1C monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0029-Ab-1/ GM-Tg-hg-MP0029-Ab-2; GM-Tg-rg-MP0029-Ab-1/ GM-Tg-rg-MP0029-Ab-2;
GM-Tg-mg-MP0029-Ab-1/ GM-Tg-mg-MP0029-Ab-2; GM-Tg-cynog-MP0029-Ab-1/ GM-Tg-cynog-MP0029-Ab-2;
GM-Tg-felg-MP0029-Ab-1/ GM-Tg-felg-MP0029-Ab-2; GM-Tg-cang-MP0029-Ab-1/ GM-Tg-cang-MP0029-Ab-2;
GM-Tg-bovg-MP0029-Ab-1/ GM-Tg-bovg-MP0029-Ab-2; GM-Tg-equg-MP0029-Ab-1/ GM-Tg-equg-MP0029-Ab-2
Products NameAnti-ACVR1C monoclonal antibody
Formatmab
Target NameACVR1C
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ACVR1C benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ACV1C/ ACVR1C/ ACVRLK7 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0029-Ag-1activin A receptor, type IC (ACVR1C) protein


    Target information

    Target IDGM-MP0029
    Target NameACVR1C
    Gene ID130399,269275,245921,697826,488361,101091037,536380,100059573
    Gene Symbol and SynonymsACTR-IC,ACVR1C,ACVRLK7,Alk-7,ALK7,C230097P10,habrec1
    Uniprot AccessionQ8NER5,P70539
    Uniprot Entry NameACV1C_HUMAN,ACV1C_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000123612
    Target ClassificationN/A

    The target: ACVR1C, gene name: ACVR1C, also named as ACVRLK7, ALK7. ACVR1C is a type I receptor for the TGFB (see MIM 190180) family of signaling molecules. Upon ligand binding, type I receptors phosphorylate cytoplasmic SMAD transcription factors, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors (Bondestam et al., 2001 [PubMed 12063393]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.